Systemic sclerosis
94 results
1 - 94
Systemic sclerosis - Incipient systemic sclerosis - Image
Exercise and physical therapy for systemic sclerosis- Ulceration at the tip of the thumb (systemic sclerosis) - Image
- Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
- Stem cell transplantation for systemic sclerosis
- Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
- Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
- Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
Pregnancy outcomes in women with systemic sclerosis worse than in general population- Methotrexate in the treatment of systemic sclerosis
- Sausage fingers, Raynaud's phenomenon and thickening of the skin (systemic sclerosis) - Image
- Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
- Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis
- Absolute cancer risk in pts with systemic sclerosis is low but higher than in general population
- Eye symptoms and signs of systemic diseases
- Raynaud's phenomenon (RP) or white finger disease
- Mixed connective tissue disease (MCTD)
- Angiotensin converting enzyme inhibitors in treatment of scleroderma renal crisis
- Videocapillaroscopy - Image
- Episodic attacks of flushing
- Rapamycin and rapalogs for tuberous sclerosis complex
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Diffuse scleroderma - Image
- Burning mouth and glossalgia
- Diseases of the spinal cord
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Phosphodiesterase 5 inhibitors for Raynaud's phenomenon
- Glatiramer acetate for multiple sclerosis
- Contraception in patients with systemic diseases
- Glatiramer acetate for multiple sclerosis
- Cyclophosphamide for multiple sclerosis
- Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon
- Dysphagia
- Disturbances of taste
- Myositis
- Primary Sjögren's syndrome
- Temperature-induced skin disorders
- Cyclophosphomide reduces dyspnea in scleroderma lung disease
- Pruritus
- Corticosteroids for treating optic neuritis
- Calcium channel blockers for primary and secondary Raynaud's phenomenon
- Transient ischaemic attack (TIA)